CURRENT EYE RESEARCH, cilt.36, sa.9, ss.804-808, 2011 (SCI-Expanded)
Purpose: To evaluate the 6-month daytime efficacy of a fixed combination of timolol and brimonidine (BTFC) versus a timolol and dorzolamide fixed combination (DTFC) as a first choice therapy in patients with pseudoexfoliation glaucoma (PXG).